Stay updated on Alternative Schedule Study for VLA15 Clinical Trial
Sign up to get notified when there's something new on the Alternative Schedule Study for VLA15 Clinical Trial page.

Latest updates to the Alternative Schedule Study for VLA15 Clinical Trial page
- CheckyesterdayChange DetectedRevision label on the page updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check8 days agoChange DetectedA Lancet Infect Dis article on dose level optimization and vaccination schedule for VLA15 was added to the Publications section and subsequently removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded a consolidated Locations section listing study sites in Connecticut and New York; removed the separate Connecticut Locations and New York Locations subsections, and updated page revision to v3.3.3.SummaryDifference0.3%

- Check51 days agoChange DetectedThe Publications section now states that publications are automatically filled from PubMed and may not all pertain to the study. The revision tag was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check58 days agoChange DetectedThe funding-status notice about potential delays due to lapse in government funding and NIH operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check73 days agoChange DetectedPublications section updated with two 2024 Lancet Infectious Diseases papers on VLA15 booster immunisation and dose optimization.SummaryDifference0.4%

Stay in the know with updates to Alternative Schedule Study for VLA15 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alternative Schedule Study for VLA15 Clinical Trial page.